Data from Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials
Steven J. Skates(Massachusetts General Hospital), Karen H. Lu(The University of Texas MD Anderson Cancer Center), David M. O’Malley(The Ohio State University), Patrick M. Sluss(Harvard University), Charles W. Drescher(Gynecologic Oncology Group), Lori M. Minasian(National Cancer Institute), Andrew Berchuck(General Marble (Greece)), Kelly‐Anne Phillips(The University of Melbourne), John F. Boggess(University of Kentucky), William J. Welch(University of British Columbia), Steven A. Elg(Iowa Lutheran Hospital), Joan L. Walker(Cornell University), Dianne M. Finkelstein(Harvard University), Carol J. Fabian(Washington Hospital), Susan Nayfield(University of Florida), Susan M. Domchek(University City Science Center), Katie Wakeley(South Shore Hospital), Gustavo Rodríguez(The University of Texas at El Paso), Powel H. Brown(The University of Texas MD Anderson Cancer Center), Robert P. Edwards(Cancer Research UK Technology), Claudine Isaacs(Georgetown University), Nora Horick(Massachusetts General Hospital), Saundra S. Buys(University of Utah), John O. Schorge(St. Jude Children's Research Hospital), Carol H. Kasten(United States Food and Drug Administration), Mark H. Greene(Cancer Institute (WIA)), Deborah K. Armstrong(Johns Hopkins University), Susan A. Davidson(Denver Health Medical Center), Edward E. Partridge(University of Alabama at Birmingham), Thomas F. Rutherford(University of Wisconsin–Madison), Mary B. Daly(Fox Chase Cancer Center), Marion Piedmonte(Cleveland Clinic), Ira Horowitz(Gynecologic Oncology Group), Mark E. Sherman(Mayo Clinic in Florida), David S. Alberts(University of Arizona), Wendy R. Brewster(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k